Company intelligence / Profile preview

Medtrum

Shanghai, Shanghai, Chinapmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~28
Development stage: Commercial

Overview

Medtrum has commercialized several medical devices for diabetes management, including tubeless insulin pumps and continuous glucose monitors. The company’s A6 TouchCare system integrates both technologies. It continues to develop a closed-loop “artificial pancreas” solution but no pivotal clinical trial results are publicly available as of June 2025. No published large-scale clinical trial data found.

Therapeutic areas: Endocrinology
Modalities: Device (specifically insulin pumps and continuous glucose monitoring systems)Digital health device (for diabetes management)
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

A7+TouchCare

Commercial

Indications: Type 1 diabetes mellitus, Type 2 diabetes mellitus

1 more asset in the full pipeline.

Request access →

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Medtrum.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medtrum.

Explore the full profile